Lisbeth Evered, BSc, MBiostats, PhD; Brendan Silbert, MB, BS, FANZCA; David A. Scott, MB, BS, FANZCA, PhD; et al.
free access
JAMA Neurol. 2018;75(5):542-547. doi:10.1001/jamaneurol.2017.4913
This study assesses neuronal injury by measuring plasma levels of neurofilament light and tau biomarkers in a series of timed collections in the 48 hours after anesthesia and surgery.
Yakeel T. Quiroz, PhD; Reisa A. Sperling, MD; Daniel J. Norton, PhD; et al.
free access
JAMA Neurol. 2018;75(5):548-556. doi:10.1001/jamaneurol.2017.4907
This cross-sectional study characterizes the associations between amyloid and tau deposits in the brains of cognitively unimpaired and impaired carriers of presenilin 1 E280A mutation.
Marco Savarese, PhD; Lorenzo Maggi, MD; Anna Vihola, PhD; et al.
free access
JAMA Neurol. 2018;75(5):557-565. doi:10.1001/jamaneurol.2017.4899
This case series identifies genetic variants associated with titinopathy in patients with muscle disorders and describes a workflow for a more straightforward and reproducible interpretation of the clinical meaning of titin variants.
Yulia Orlova, MD, PhD; Paul Rizzoli, MD; Elizabeth Loder, MD, MPH
free access
JAMA Neurol. 2018;75(5):566-572. doi:10.1001/jamaneurol.2017.5144
This population-based cohort study assesses the risk of serotonin syndrome associated with concomitant use of triptans and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants.
Karim Wahbi, MD; Raphaël Porcher, PhD; Pascal Laforêt, MD; et al.
free access
JAMA Neurol. 2018;75(5):573-581. doi:10.1001/jamaneurol.2017.4778
This cohort study aims to develop and validate a prognostic score to predict 10-year survival in patients with myotonic dystrophy type 1.
Erik S. Musiek, MD, PhD; Meghana Bhimasani, BS; Margaret A. Zangrilli; et al.
free access
JAMA Neurol. 2018;75(5):582-590. doi:10.1001/jamaneurol.2017.4719
This study examines the associations between circadian function, aging, and preclinical Alzheimer disease pathology in cognitively normal adults.
Marie Coutelier, MD, PhD; Monia B. Hammer, PhD; Giovanni Stevanin, PhD; et al.
free access
JAMA Neurol. 2018;75(5):591-599. doi:10.1001/jamaneurol.2017.5121
This cohort study assesses the efficacy of exome-targeted capture sequencing to detect mutations in genes broadly linked to cerebellar ataxia and investigates their prevalence in a large cohort of undiagnosed patients with various phenotypic presentations.
Angela Rosenbohm, MD; Gabriele Nagel, MD; Raphael S. Peter, MSc; et al.
free access
JAMA Neurol. 2018;75(5):600-607. doi:10.1001/jamaneurol.2017.5129
This case-control cohort study investigates the association between the onset and prognosis of amyotrophic lateral sclerosis and serum retinol-binding protein 4 concentration as a biomarker for insulin resistance and vitamin A metabolism.
Sylvia Villeneuve, PhD; Jacob W. Vogel, BA; Julie Gonneaud, PhD; et al.
free access
JAMA Neurol. 2018;75(5):608-619. doi:10.1001/jamaneurol.2017.5135
This cohort study assesses the association between proximity to parental symptom onset and amyloid-β burden in asymptomatic individuals with a parental history of sporadic Alzheimer disease.